623 related articles for article (PubMed ID: 10392960)
21. Autologous transplantation of retrovirally transduced bone marrow or neonatal blood cells into cats can lead to long-term engraftment in the absence of myeloablation.
Simonaro CM; Haskins ME; Abkowitz JL; Brooks DA; Hopwood JJ; Zhang J; Schuchman EH
Gene Ther; 1999 Jan; 6(1):107-13. PubMed ID: 10341882
[TBL] [Abstract][Full Text] [Related]
22. Retroviral-mediated transfer of the murine interleukin-3 gene engineered for intracellular retention results in a myeloproliferative syndrome but is associated with circulating interleukin-3 levels.
Orchard PJ; Detrick RA; Gorden K; Dunbar CE; Vallera DA; Taylor P; McIvor RS; Blazar BR
Exp Hematol; 1993 Aug; 21(9):1245-54. PubMed ID: 8330649
[TBL] [Abstract][Full Text] [Related]
23. Induction of graft versus leukemia effect in bone marrow transplantation: dosage and time schedule dependency of interleukin 2 therapy.
Charak BS; Brynes RK; Katsuda S; Groshen S; Chen SC; Mazumder A
Cancer Res; 1991 Apr; 51(8):2015-20. PubMed ID: 2009520
[TBL] [Abstract][Full Text] [Related]
24. Immunotherapy with interleukin-2 after hematopoietic cell transplantation for hematologic malignancy.
Margolin K; Forman SJ
Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S33-8. PubMed ID: 10685656
[TBL] [Abstract][Full Text] [Related]
25. Drug selection of MDR1-transduced hematopoietic cells ex vivo increases transgene expression and chemoresistance in reconstituted bone marrow in mice.
Licht T; Goldenberg SK; Vieira WD; Gottesman MM; Pastan I
Gene Ther; 2000 Feb; 7(4):348-58. PubMed ID: 10694816
[TBL] [Abstract][Full Text] [Related]
26. Hematopoietic reconstitution after lethal irradiation and bone marrow transplantation: effects of different hematopoietic cytokines on the recovery of thymus, spleen and blood cells.
Frasca D; Guidi F; Arbitrio M; Pioli C; Poccia F; Cicconi R; Doria G
Bone Marrow Transplant; 2000 Feb; 25(4):427-33. PubMed ID: 10723587
[TBL] [Abstract][Full Text] [Related]
27. Photochemical treatment with S-59 psoralen and ultraviolet A light to control the fate of naive or primed T lymphocytes in vivo after allogeneic bone marrow transplantation.
Truitt RL; Johnson BD; Hanke C; Talib S; Hearst JE
J Immunol; 1999 Nov; 163(9):5145-56. PubMed ID: 10528221
[TBL] [Abstract][Full Text] [Related]
28. Expanded donor natural killer cell and IL-2, IL-15 treatment efficacy in allogeneic hematopoietic stem cell transplantation.
Chen G; Wu D; Wang Y; Cen J; Feng Y; Sun A; Tang X; Chang H; Zhu Z
Eur J Haematol; 2008 Sep; 81(3):226-35. PubMed ID: 18573173
[TBL] [Abstract][Full Text] [Related]
29. Potent graft antitumor effect in natural killer-resistant disseminated tumors by transplantation of interleukin 2-activated syngeneic bone marrow in mice.
Agah R; Malloy B; Kerner M; Girgis E; Bean P; Twomey P; Mazumder A
Cancer Res; 1989 Nov; 49(21):5959-63. PubMed ID: 2790810
[TBL] [Abstract][Full Text] [Related]
30. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
Talmadge JE
Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
[TBL] [Abstract][Full Text] [Related]
31. [Reconstitution and protection of murine hematopoiesis by second transplantation with bone marrow cells containing mutant human DHFR gene from primary generation murine].
Zhang W; Xu Z; Xu G
Zhonghua Xue Ye Xue Za Zhi; 1999 Jun; 20(6):300-2. PubMed ID: 11721387
[TBL] [Abstract][Full Text] [Related]
32. A murine model of antimetabolite-based, submyeloablative conditioning for bone marrow transplantation: biologic insights and potential applications.
Goebel WS; Pech NK; Meyers JL; Srour EF; Yoder MC; Dinauer MC
Exp Hematol; 2004 Dec; 32(12):1255-64. PubMed ID: 15588950
[TBL] [Abstract][Full Text] [Related]
33. Physiology of natural killer cells. In vivo regulation of progenitors by interleukin 3.
Kalland T
J Immunol; 1987 Dec; 139(11):3671-5. PubMed ID: 3500227
[TBL] [Abstract][Full Text] [Related]
34. Myeloablation enhances engraftment of transduced murine hematopoietic cells, but does not influence long-term expression of the transgene.
Puig T; Kádár E; Limón A; Cancelas JA; Eixarch H; Luquín L; García M; Barquinero J
Gene Ther; 2002 Nov; 9(21):1472-9. PubMed ID: 12378410
[TBL] [Abstract][Full Text] [Related]
35. Introduction of the green fluorescent protein gene into hematopoietic stem cells results in prolonged discrepancy of in vivo transduction levels between bone marrow progenitors and peripheral blood cells in nonhuman primates.
Hanazono Y; Terao K; Shibata H; Nagashima T; Ageyama N; Asano T; Ueda Y; Kato I; Kume A; Hasegawa M; Ozawa K
J Gene Med; 2002; 4(5):470-7. PubMed ID: 12221639
[TBL] [Abstract][Full Text] [Related]
36. [Transplantation of mesenchymal derived stem cells followed by G-CSF injection can reconstitute hematopoiesis of lethally irradiated BALB/c mice].
Hu Y; Ma L; Ma GJ; Jiang XY; Zhao CH
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Feb; 24(1):20-4. PubMed ID: 12905834
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of CD26 peptidase activity significantly improves engraftment of retrovirally transduced hematopoietic progenitors.
Tian C; Bagley J; Forman D; Iacomini J
Gene Ther; 2006 Apr; 13(7):652-8. PubMed ID: 16341058
[TBL] [Abstract][Full Text] [Related]
38. Hematopoietic transforming potential of activated ras in chimeric mice.
Hawley RG; Fong AZ; Ngan BY; Hawley TS
Oncogene; 1995 Sep; 11(6):1113-23. PubMed ID: 7566971
[TBL] [Abstract][Full Text] [Related]
39. Selective expression of methotrexate-resistant dihydrofolate reductase (DHFR) activity in mice transduced with DHFR retrovirus and administered methotrexate.
Vinh DB; McIvor RS
J Pharmacol Exp Ther; 1993 Nov; 267(2):989-96. PubMed ID: 8246174
[TBL] [Abstract][Full Text] [Related]
40. Improved hematopoietic stem cell engraftment following ex vivo expansion of murine marrow cells with SCF and Flt3L.
Diehl A; Stoelting S; Nadrowitz R; Wagner T; Peters SO
Cytotherapy; 2007; 9(6):532-8. PubMed ID: 17882717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
